|
Trinity Biosystems is actively seeking collaborative opportunities to apply its proprietary TriPex™ system to partner companies' high-value target macromolecules with the goal of improving their therapeutic profile, improving health outcomes and expanding their commercial potential. The TriPex™ system is suited to protein, peptide and antibody payloads, and can be customized to accommodate the technical requirements of a wide range of macromolecules.
Trinity is interested in talking with companies that would like to explore the applicability of the TriPex™ system to their development-stage macromolecules as well as to already marketed products in a broad range of therapeutic areas. Trinity is also interested in talking with potential partners about collaborating on the development of its internal pipeline.
Trinity is making rapid advances in generating a robust preclinical data package that will provide a strong foundation for advancing its lead diabetes drug candidate into clinical development.
For more information about potential partnership opportunities with Trinity Biosystems, please contact: busdev@trinitybiosystems.com.
| 
